Tyra Biosciences develops oral small molecule drug candidates for cancers and genetically defined conditions, based in Carlsbad, California. TYRA reports earnings on Wed, Nov 4, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 22 | Oppenheimer | Reiterated | Buy | |
| Sep 22 | HC Wainwright & Co. | Target lowered | Buy | |
| Sep 10 | HC Wainwright & Co. | Target lowered | Buy | |
| Sep 4 | HC Wainwright & Co. | Reiterated | Buy | |
| Jun 17 | Jones Trading | Initiated | Buy |
Whale Options Flow
90DNo whale options trades in TYRA in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TYRA is in one of them and how their past TYRA trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered TYRA in an article yet. Here's the latest on the wider market.
About Tyra Biosciences
Tyra Biosciences is a biotechnology company based in Carlsbad, California. It develops oral medicines for urothelial cancers, which affect the bladder and urinary tract, and for achondroplasia, a bone growth condition in children. Its drug candidates are still in clinical trials and have not been approved for sale. The company designs them with its own in-house platform, aiming to serve patients with these cancers and conditions.
- Headquarters
- Carlsbad, CA